Effects of Ayres Sensory Integration Therapy Versus Conservative Treatment in Autism Spectrum

Effects of Ayres Sensory Integration Therapy Versus Conservative Treatment in Autism Spectrum

Study Overview

• Status: Active, not recruiting
• Conditions: Autism Spectrum Disorder
• Intervention / Treatment: Diagnostic test: Ayres sensory integration therapy; Diagnostic test: Behaviour Therapy

Detailed Description

"This study named effects of ayres sensory integration therapy versus conservative treatment in autism spectrum is a randomized clinical trail study.There is no evidence-based intervention protocol to treat sensory integration dysfunction in autism spectrum. This study may help finding best therapeutic treatment approach for sensory integration dysfunction results in repetitive behavior and impairments in functionality in autism spectrum.This study helps

• To evaluate best intervention plan for sensory integration dysfunction, Ayres sensory integration therapy versus conservative treatment in autism spectrum.
• To determine how many patients will be having what type of sensory integration dysfunction that come with autism spectrum leading to certain level of functional restrictions in Activity of Daily Livings (ADLs).
• Which type of sensory integration dysfunction having greater functional impairment and need to be focused more for intervention?
• To make better individualized rehabilitation treatment plan being an Occupational Therapist."

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Pakistan
  • Punjab
    • Faisalabad, Punjab, Pakistan
      • RICCER Institute

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Diagnosed cases of autism age range from 2 year to 8 years.
• All patients will be assed using sensory profile by Winnie Dunn.
• All the patients fulfilling the above-mentioned inclusion criteria will be assessed and evaluated by occupational therapist for sensory integration dysfunction.

Exclusion Criteria:

• All other patients not having diagnosed as autism spectrum criteria are excluded.
• All patients with sensory processing disorder assessed by using sensory profile.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Ayres sensory integration therapy; A. Jean Ayres, is a theory and practice that targets a person's ability to process and internally integrate sensory information from their body and environment.	Diagnostic test: Ayres sensory integration therapy; A. Jean Ayres, is a theory and practice that targets a person's ability to process and internally integrate sensory information from their body and environment. Sensory information may be visual, auditory, tactile, proprioceptive, and/or vestibular in nature. ASI uses individually tailored activities that utilize "just right" challenges to an individual's existing patterns of sensory processing and motor planning and encourage movement and organization of self in time and space. ASI incorporates specialized equipment and materials in purposeful and playful activities in order to improve adaptive behavior.
Other: Behaviour therapy; The current treatment options for the core symptoms of autism are limited to psychosocial therapies, such as applied behavior analysis.	Diagnostic test: Behaviour Therapy; The current treatment options for the core symptoms of autism are limited to psychosocial therapies, such as applied behavior analysis. Medications have been most effective in treating the associated behavioral symptoms of autism, though studies have examined potential benefits in some of the core symptoms of autism with certain medications, especially the repetitive behaviors often seen with this diagnosis. Risperidone and aripiprazole are currently the only medications FDA approved for symptoms associated with autism spectrum disorders, targeting the irritability often seen with this diagnosis.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
sensory profile by winnie dunn	sensory profile by winnie dunn willl be used to measure primary outcomes or initial assessment	12 Months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
sensory profile by winnie dunn	sensory profile by winnie dunn will be used to measure secondary outcomes or post intervention/treatment reassessment	12 Months

Collaborators and Investigators

• Sponsor: Superior University

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2023
• Primary Completion (Estimated): June 1, 2024
• Study Completion (Estimated): September 30, 2024

Study Registration Dates

• First Submitted: April 16, 2024
• First Submitted That Met QC Criteria: April 16, 2024
• First Posted (Actual): April 18, 2024

Study Record Updates

• Last Update Posted (Actual): April 22, 2024
• Last Update Submitted That Met QC Criteria: April 18, 2024
• Last Verified: April 1, 2024

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Mental Disorders; Neurodevelopmental Disorders; Child Development Disorders, Pervasive; Autistic Disorder; Autism Spectrum Disorder
• Other Study ID Numbers: MSRSW/Batch-Fall22/700

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No